Medium Article: https://medium.com/@jsmith0475/building-human-facing-agentic-systems-the-psychology-and-sociology-of-super-intelligence-1571cf565d51

Dr. Jerry Smith's January 2025 Medium article explores the psychological, sociological, and ethical implications of "human-facing agentic systems," AI powered by large language models (LLMs). These systems, leveraging multi-headed attention mechanisms, aim to collaborate with humans, not merely serve as tools. The article emphasizes the potential for both empowerment and manipulation inherent in these systems, highlighting the crucial role of self-interest, emotion, and identity in human-AI interaction. Smith concludes with a call for responsible development guided by transparency, inclusivity, and justice, warning against the potential for these systems to become instruments of control.

Building Human-Facing Agentic Systems: The Psychology and Sociology of Super Intelligence

Medium Article: https://medium.com/@jsmith0475/how-ai-just-cracked-pharmaceutical-method-development-in-6-weeks-instead-of-12-months-492efc9a23a2
This article from an article by Dr. Jerry A. Smith that introduces a novel solution for achieving deterministic AI outputs essential for drug development regulation. It explains that pharmaceutical method development, a process currently taking up to twelve months, is stalled by the FDA's requirement for identical, reproducible results from AI, which probabilistic Large Language Models (LLMs) cannot naturally provide. The core breakthrough involves applying a 160-year-old mathematical concept, Maxwell's electromagnetic gauge theory, to constrain the internal workings of transformer models. By implementing a framework called cognitive anchoring with four mechanisms—symbolic, temporal, spatial, and symmetry anchoring—the research successfully channels the model’s internal representational freedom without compromising its semantic reasoning, achieving a high degree of functional determinism and potentially reducing method development time significantly. This innovation promises to unlock massive efficiency gains, reduce drug development costs, and accelerate patient access to therapies by making AI outputs acceptable for GMP (Good Manufacturing Practices) compliance.

How AI Just Cracked Pharmaceutical Method Development - In 6 Weeks Instead of 12 Months

In-Depth Explorations of Neuroscience-Inspired Architectures Revolutionizing AI.

How AI Just Cracked Pharmaceutical Method Development - In 6 Weeks Instead of 12 Months

Dr. Jerry A. Smith

Related tracks